liveroulettewheel| Watson Biotech actively promotes the research and development of 9-valent HPV vaccines, and its market expansion strategy has achieved results.

Date: 5个月前 (04-13)View: 78Comments: 0

Watson Biological response Vaccine batch delivery volume is not equal to sales volume, actively promoting clinical research of 9-valent HPV products.

April 12, targeted at investors on the batch delivery of vaccinesLiveroulettewheelWatson Biology (300142) responded to the question. The company pointed out that the batch delivery of vaccine products is not equal to sales, which is affected by many factors, such as the dynamic balance of finished product inventory and the guarantee of inventory validity.

Watson Biology said that the company is comprehensively judging the production cycle of specific products according to market demand and production cycle, and actively promotes the clinical development plan of 9-price HPV products. At the same time, the company will maintain close communication with CDE and strive to carry out clinical research on the effectiveness of protection with the optimal strategy.

On the issue of the proportion of sales expenses, Watson Biology said that the company's sales expense rate is at the average level of comparable companies in the same industry, and will continue to strengthen the work related to increasing revenue and reducing expenditure, improving quality and increasing efficiency. The company emphasizes that the cost input should be matched with the enterprise development stage, strategic layout, market competition pattern and industry maturity.

Watson Biology also mentioned that China's vaccine industry and overseas market space is still large, the company is in the stage of domestic and foreign market expansion, need to use considerable resources to ensure long-term development in the future. The company attaches great importance to the situation of the secondary market, and said that the new share repurchase plan will be combined with the company's development and market conditions, strictly comply with the standard operating procedures of listed companies to make decisions.

liveroulettewheel| Watson Biotech actively promotes the research and development of 9-valent HPV vaccines, and its market expansion strategy has achieved results.

Risk Tip of Hexun self-selected WriterLiveroulettewheelThe above content is only the views of the author or guest, does not represent any position of Hexun, and does not constitute any investment suggestions related to Hexun. Before making any investment decision, investors should consider the risk factors related to investment products according to their own circumstances and consult professional investment advisers if necessary. Hexun tries its best but cannot confirm the authenticity, accuracy and originality of the above content, and Hexun does not make any guarantee or commitment.

Tags:

Prev: dreamscasino50free| St. Martin International (00482.HK)'s 2023 annual revenue is approximately HK$562 million
Next: texasholdemlive| Investment strategy brief writing skills: How to write an effective investment strategy brief